Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Anormed initiates trial of novel HIV inhibitor
In order to enter and infect cells HIV must bind to either the CXCR4 or CCR5 receptor, AMD070 is designed to stop the virus from entering the cells
In order to enter and infect cells HIV must bind to either the CXCR4 or CCR5 receptor, AMD070 is designed to stop the virus from entering the cells
YSPSL was developed by Wyeth and was acquired by Y’s Therapeutics from an undisclosed California biotechnology company in June 2005, providing Y’s with an exclusive, worldwide license from
At closing, Neurobiological Technologies Inc (NTI) received $20 million and will receive an additional $13 million, payable in installments through January 2007. Celtic Pharma and NTI will collaborate
Alza originally submitted the application for licensure of Ionsys to the FDA in September 2003, but received an approvable letter from the FDA in mid-2004 informing the company
Under the terms of the deal, Valeant will pay $113.5 million in cash upon closing, and subsequent milestone payments of up to approximately $22.5 million. Valeant will also
The first collaboration will focus upon a group of compounds that target the NMDA 2B receptor and will be developed for the treatment of chronic pain and other
Myasthenia gravis (MG) is a debilitating, chronic autoimmune neuromuscular disease in which the body produces auto-antibodies that prevent the nerves from sending messages to the muscles. The randomized,
The investigator-initiated clinical study will take place at the Yale University School of Medicine and will enroll 60 women with recurrent epithelial ovarian, fallopian tube or abdominal cavity
“There is no question that obesity is the underlying cause,” said Dr Victoria Chan, registrar in the clinical medicine department at the hospital, and lead author of the
The scientists in the collaboration isolated UHRF1 from a functional genomics screen designed to identify genes that interfere with proliferation. They found that UHRF1 expression is elevated in